• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS US CORP PRECISE PRO RX OUS; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS US CORP PRECISE PRO RX OUS; STENT, CAROTID Back to Search Results
Catalog Number PC0740XCE
Device Problem Difficult or Delayed Positioning (1157)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/08/2023
Event Type  malfunction  
Manufacturer Narrative
This device is available for analysis, but the engineering report is not yet available.However, it will be submitted within 30 days upon receipt.Additional information is pending and will be submitted within 30 days upon receipt.
 
Event Description
As reported, the delivery rod on a 7mm x 40mm precise pro rx stent delivery system was found bent upon opening the package.The stent was found to be deployed partially after being removed from the packaging.The product did not enter the body.The procedure was completed by replacing the complaint device with another pc stent.There were no reports of patient injury.The physician has been trained and has used the device properly in the past.The surgeon tried to retrieve it but failed.There was no difficulty removing the product from the packaging.The device was stored and prepped in accordance with the instructions for use (ifu).The device will be returned for evaluation.Addendum: the device was returned with the stent partially deployed.
 
Manufacturer Narrative
After further review of additional information received the following sections have been updated accordingly: g3, g6, h2, h3, h6, and h10.Complaint conclusion: as reported, the delivery rod on a 7mm x 40mm precise pro rx stent delivery system was found bent upon opening the package.The stent was found to be deployed partially after being removed from the packaging.The product did not enter the body.The procedure was completed by replacing the complaint device with another pc stent.There were no reports of patient injury.The physician has been trained and has used the device properly in the past.The surgeon tried to retrieve it but failed.There was no difficulty removing the product from the packaging.The device was stored and prepped in accordance with the instructions for use (ifu).The device was returned for analysis.A non-sterile ¿precise pro rx ous carotid sys¿ was received coiled inside of a clear plastic bag.The device was unpacked to proceed with the product evaluation.The unit was thoroughly inspected observing that it does not present any damages or anomalies.The device was already deployed before it¿s arrival to cordis laboratory the stent was observed in the bag loose and separated from the device manufacturing position.A functional analysis was attempted to be executed to determine if the deployment mechanism was not compromised in the received unit.This analysis could not be fully evaluated as the stent was not in manufacturing position.Nevertheless, the stent delivery mechanism was activated after the device was prepped per the instructions for use, flushing of the unit was performed and loosening of the torque component.The reported ¿stent delivery system (sds) deployment difficulty premature deployment¿ and ¿stent delivery system (sds) kinked/bent¿ were not confirmed as the stent was received already deployed in the bag received for analysis.The exact cause of the issue experienced by the customer could not be determined.Functionality of the deployment mechanism was tested with no difficulties noted.Additionally, no kinks or other damages were noted to the device upon analysis.Therefore, based on the information available for review and product analysis, it is not possible to determine what factors may have contributed to the issue experienced by the customer.According to the instructions for use, which is not intended to mitigate risk, ¿extract the stent delivery system from the tray.Examine the device for any damage.Evaluate the distal end of the catheter to ensure that the stent is contained within the outer sheath.Do not use if the stent is partially deployed.Note: if resistance is met during delivery system introduction, the system should be withdrawn and another system should be used.Note: if any resistance is met during delivery system withdrawal, advance the outer sheath until the outer sheath marker contacts the catheter tip and withdraw the system as one unit.Initiate stent deployment by retracting the outer sheath while holding the inner shaft in a fixed position.Deployment is complete when the outer sheath marker passes the proximal inner shaft stent marker.Note: the mechanism for stent deployment is outer sheath retraction.Deployment is completed by maintaining inner shaft position while retracting the outer sheath and allowing the stent to expand (often referred to as the ¿pin-and-pull¿ method).Post-deployment stent dilatation: while using fluoroscopy, withdraw the entire delivery system as one unit, over the guidewire and out of the body.Remove the delivery device from the guidewire.Note: if any resistance is met during delivery system withdrawal, advance the outer sheath until the outer sheath marker contacts the catheter tip and withdraw the system as one unit.(do not remove guidewire.) using fluoroscopy, visualize the stent to verify full deployment.If incomplete expansion exists within the stent at any point along the lesion, post deployment balloon dilatation (standard pta technique) can be performed.¿ the information available does not suggests a design or manufacturing related cause for the reported event.Therefore, no corrective or preventive action will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRECISE PRO RX OUS
Type of Device
STENT, CAROTID
Manufacturer (Section D)
CORDIS US CORP
14021 nw 60 avenue
miami lakes, florida 33014
Manufacturer (Section G)
CORDIS US CORP.
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer Contact
karla castro
santiago troncoso 808
juarez, chihuahua 
7863138372
MDR Report Key18519384
MDR Text Key332940332
Report Number9616099-2024-00016
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
UNKNOWN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/15/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/16/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberPC0740XCE
Device Lot Number18198294
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/21/2023
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received03/11/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/04/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-